Page 8 - Skin Sciences News Today

STRATA Skin Sciences Reports Record Fourth Quarter 2021 Revenue Horsham, Pa, March 21, 2022 -STRATA Skin Sciences, Inc. , a medical... | March 21, 2022

STRATA Skin Sciences (NASDAQ:SSKN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC […]

HORSHAM, Pa., March 14, 2022 -- STRATA Skin Sciences, Inc. , a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of... | March 14, 2022

HORSHAM, Pa., Feb. 14, 2022 -- STRATA Skin Sciences, Inc. , a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic... | February 14, 2022

Healio Psoriatic Disease | Topical steroids have remained a mainstay first-line treatment for psoriasis, but two new drugs in development aim to revolutionize how topical drugs are used in treatment of the disease.“We’ve had a decent amount of minor innovation in psoriasis,” Mark G. Lebwohl, MD, dean for clinical therapeutics and chair emeritus of the Kimberly and Eric J. Waldman Department of Dermatology

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

HORSHAM, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,...

/PRNewswire/ -- The global dermatology excimer laser market size is expected to reach USD 955.5 million by 2028, according to a new report by Grand View...

STRATA Skin Sciences Reports First Quarter 2021 Financial Results HORSHAM, Pa., May 12, 2021 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended March 31, 2021. Recent Highlights Total revenue for the first quarter of 2021 was $5.8 million, a decrease of 13.4% as compared to the...

DIRECTORS of the Bradford Burns Unit have thanked fundraisers for continued support on the 36th anniversary of the City Fire Disaster.